ATF2 (Ab 71 of 53) Antilichaam

Transcriptional activator, probably constitutive, which binds to the cAMP-responsive element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), a sequence present in many viral and cellular promoters. Interaction with JUN redirects JUN to bind to CRES preferentially over the 12-O-tetradecanoylphorbol-13-acetate response elements (TRES) as part of an ATF2-c-Jun complex.

1386

P15336

NP_001871.2

Human

ATF2 (Ab-71 or 53) antibody was raised against a peptide sequence around aa.69~73 or 51~55 (T-P-T-P-T) derived from Human ATF2.

Unconjugated

Primary Antibodies

Other

Antibodies were purified by affinity-chromatography using epitope-specific peptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

None

Blue Ice

Store antibody at -20˚ C for up to one year.

65 - 75 kDa

This antibody detects endogenous level of total ATF2 protein.

Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100, Immunofluorescence: 1:100~1:200

ATF2

Activating transcription factor 2

Homo sapiens

Sevilla A, et al. (2004) J Biol Chem. 279 (26) : 27458-27465. Waetzig G H, et al. (2002) J Immunol. 168 (10) : 5342-5351. Abdel-Hafiz H A, et al. (1992) Mol Endocrinol. 6: 2079-2089. Gupta S, et al. (1995) Science. 267: 389-393. Van Dam H, et al. (1995) EMBO J. 14 (8) : 1798-1811.

HB16, CREB2, TREB7, CREB-2, CRE-BP1, FKHL13, HFH4, CREBP1

WB, IHC, IF

22538422

Liquid